Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

324 ARTÍCULOS , VIENDO DEL 16 AL 30

Preclinical studies of potential amyloid binding PET/SPECT ligands in Alzheimer's disease

Svedberg MM, Rahman O, Hall H.

Nucl Med Biol. 2012 May;39(4):484-501. doi: 10.1016/j.nucmedbio.2011.10.007. Epub 2012 Jan 5.

Evaluation of the screening power of Cognitive Abilities Screening Instrument for probable Alzheimer's disease using voxel-based morphometry

Mok GS, Wu YY, Lu KM, Wu J, Chen LK, Wu TH.

Clin Imaging. 2012 Jan-Feb;36(1):46-53. doi: 10.1016/j.clinimag.2011.03.004.

[The most cited work in the 36th year of "Psychiatrischen Praxis." Congratulations!]

Riedel-Heller SG.

Psychiatr Prax. 2012 Jan;39(1):3. doi: 10.1055/s-0031-1298836. Epub 2012 Jan 10.

Amyloid-β oligomers induce differential gene expression in adult human brain slices

Sebollela A, Freitas-Correa L, Oliveira FF, Paula-Lima AC, Saraiva LM, Martins SM, Mota LD, Torres C, Alves-Leon S, de Souza JM, Carraro DM, Brentani H, De Felice FG, Ferreira ST.

J Biol Chem. 2012 Mar 2;287(10):7436-45. doi: 10.1074/jbc.M111.298471. Epub 2012 Jan 10.

Peptides for therapy and diagnosis of Alzheimer's disease

Funke SA, Willbold D.

Curr Pharm Des. 2012;18(6):755-67. doi: 10.2174/138161212799277752.

Resumption of food and fluid intake in Alzheimer's disease with severe apathy following intravenous citalopram

Hellen F, Supprian T, Salamon T, Lange-Asschenfeldt C.

Psychiatry Clin Neurosci. 2012 Feb;66(1):82. doi: 10.1111/j.1440-1819.2011.02294.x.

Interview for Deterioration in Daily Living Activities in Dementia: construct and concurrent validity in patients with mild to moderate dementia

Voigt-Radloff S, Leonhart R, Schützwohl M, Jurjanz L, Reuster T, Gerner A, Marschner K, van Nes F, Graff M, Vernooij-Dassen M, Rikkert MO, Holthoff V, Hüll M.

Int Psychogeriatr. 2012 Mar;24(3):382-90. doi: 10.1017/S1041610211001785.

Early AD pathology in a [C-11]PiB-negative case: a PiB-amyloid imaging, biochemical, and immunohistochemical study

Ikonomovic MD, Abrahamson EE, Price JC, Hamilton RL, Mathis CA, Paljug WR, Debnath ML, Cohen AD, Mizukami K, DeKosky ST, Lopez OL, Klunk WE.

Acta Neuropathol. 2012 Mar;123(3):433-47. doi: 10.1007/s00401-012-0943-2. Epub 2012 Jan 24.

Clinical and research diagnostic criteria for Alzheimer's disease

Sarazin M, de Souza LC, Lehéricy S, Dubois B.

Neuroimaging Clin N Am. 2012 Feb;22(1):23-32,viii. doi: 10.1016/j.nic.2011.11.004.

Structural neuroimaging in aging and Alzheimer's disease

Vernooij MW, Smits M.

Neuroimaging Clin N Am. 2012 Feb;22(1):33-55, vii-viii. doi: 10.1016/j.nic.2011.11.007.

Nonhuman primate models of Alzheimer-like cerebral proteopathy

Heuer E, Rosen RF, Cintron A, Walker LC.

Curr Pharm Des. 2012;18(8):1159-69. doi: 10.2174/138161212799315885.

Can target-to-pons ratio be used as a reliable method for the analysis of [11C]PIB brain scans?

Edison P, Hinz R, Ramlackhansingh A, Thomas J, Gelosa G, Archer HA, Turkheimer FE, Brooks DJ.

Neuroimage. 2012 Apr 15;60(3):1716-23. doi: 10.1016/j.neuroimage.2012.01.099. Epub 2012 Jan 27.

Are clinical diagnoses of Alzheimer's disease and other dementias affected by education and self-reported race?

Teresi JA, Grober E, Eimicke JP, Ehrlich AR.

Psychol Assess. 2012 Sep;24(3):531-44. doi: 10.1037/a0027008. Epub 2012 Feb 6.

Interactive medical case. A startling decline

Vaidya A, Dolan BM, Edlow BL, Rinne ML, McGinnis SM.

N Engl J Med. 2012 Feb 9;366(6):e11. doi: 10.1056/NEJMimc1109704.

Dignity therapy: a feasibility study of elders in long-term care

Chochinov HM, Cann B, Cullihall K, Kristjanson L, Harlos M, McClement SE, Hack TF, Hassard T.

Palliat Support Care. 2012 Mar;10(1):3-15. doi: 10.1017/S1478951511000538.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias